Navigation Links
Neuromonics Names Eula Adams CEO
Date:11/19/2013

WESTMINSTER, Colo. (PRWEB) November 19, 2013

Neuromonics, Inc., manufacturer and distributor of clinically proven tinnitus treatment devices, has named Eula Adams CEO.

“Eula Adams brings a strong international business base to Neuromonics, with a wealth of financial and organizational experience,” says Ron West, chairman of the board of directors for Neuromonics. “This step can have significant impact on the company’s customers and employees, as well as the audiology industry.”

With nearly 40 years of experience in the financial accounting, financial services and technology industries, Adams has most recently served as president of Denver-based Xcore Corporation. The company designs, assembles and markets a line of low-cost, low-maintenance and low-energy netbooks, keyboard and touch-pad computing devices for global distribution.

Previously, Adams served as senior vice president of storage sales and services for Sun Microsystems, and as president and senior vice president of First Data Corporation, working in Denver. Within First Data, he held the positions of president of Merchant Services, president of Card Issuer Services and president of Teleservices. He also was chief operating officer of Western Union, later acquired by First Data. Earlier in his career, the new CEO spent 19 years with Deloitte, in the greater Atlanta area and in New York City. He was partner in charge of the Atlanta office audit group.

Adams holds a Bachelor of Science degree from Morris Brown College (Atlanta) and a Master of Business Administration degree from Harvard University. He is a licensed certified public accountant in the state of Colorado.

“I am excited to be part of the company’s growth, nationally and internationally,” says Adams. “This is a tremendous opportunity to be a vital part of the medical device and bioscience community, and to chance to help make a difference, with Neuromonics products and treatments, in the lives of those suffering from tinnitus.”

Neuromonics’ FDA-cleared devices and treatments help indiviudals with tinnitus, the condition described as ringing in the ears when no external sounds are present. According to the American Tinnitus Association, more than 50 million people in the United States suffer from the condition. Usually brought on by exposure to loud noise, the problem is especially significant in the military, with more than 34 percent of returning veterans from Iraq and Afghanistan suffering from the condition.

Neuromonics, Inc. (http://www.neuromonics.com)
Based in Westminster, Colo., Neuromonics, Inc., manufactures and distributes clinically proven, FDA-cleared medical devices to treat tinnitus. The Sanctuary provides situational relief for those suffering from mild to moderate tinnitus. The patented and clinically proven Oasis, working the Neuromonics Tinnitus Treatment, provides long-term significant relief for those with severe tinnitus. With research and development beginning in the early 1990s, Neuromonics has helped thousands of tinnitus sufferers improve their quality of life and overcome the daily life challenges associated with tinnitus. Neuromonics’ tinnitus treatments have been featured on national news media including “The Doctors” and CNN.

(end)

Read the full story at http://www.prweb.com/releases/2013/11/prweb11341526.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Neuromonics Unveils New Device to Relieve Mild, Moderate Tinnitus at Audiology NOW!
2. Humility of Mary Health Partners Names Kathy Cook New President of St. Joseph Health Center
3. IDSA announces new open access journal, names Paul Sax, M.D., editor
4. Youth Town Board Names Pepper Pratt as New Executive Director
5. NameJet Offering Premium Domain Names from Find Your Domain
6. URAC Names 2013 Health Care Stars! Award Winners at Annual Quality Summit and Awards Program
7. Becker's Healthcare Names "50 of the Greenest Hospitals in America"
8. Excelsius Surgical, LLC Names Fred Moll and Rich Grant to Board of Directors
9. Super Lawyers Names Parker Waichman LLP’s Daniel C. Burke and William J. Dubanevich to 2013 List of Top Personal Injury Lawyers in New York State
10. IBCCES Acquires IIES and Names Lyndsey Herrman as CEO
11. Queen of Reinvention's 3-day Training Brings Together Biggest Names for Reinventing Life, Business and Relationships, Starting September 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project ... 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 in ... for using telemedicine to improve the lives of the poor and underserved in other ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Today, Bright Pink , a national non-profit ... women, names a new CEO. , Bright Pink is proud to announce Katie Thiede ... be moving to a new role as Chairman of the Board and launched a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 19, 2017 Cardiology devices segment is anticipated to ... The Cardiology Devices segment is likely to create absolute ... in 2018 over 2017. By the end of 2027, Cardiology ... to US$ 700 Mn, expanding at a CAGR of 18.4% ... Asia Pacific reprocessed medical devices market ...
(Date:4/19/2017)... -- Global Surgical Drainage Device Market: Overview ... excess liquid and air. The fluid to be drained ... Surgical drains are used in a wide variety of ... surgery, neurosurgery, plastic surgery etc. Common use of surgical ... fluid e.g. blood or pus. Surgical drains are available ...
Breaking Medicine Technology: